UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

AKERS BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)

 

New Jersey   22-2983783
(State of incorporation or organization)   (I.R.S. Employer Identification No.)

 

201 Grove Road

Thorofare, New Jersey 08086

(Address of principal executive offices)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

  Title of each class Name of each exchange which
to be so registered each class is to be registered
  Common Stock, no par value per share The NASDAQ Stock Market LLC
     

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. Q

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ¨ 

 

Securities Act registration statement file number to which this form relates: 333-190456

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 

 
 

 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1. Description of Registrant’s Securities to be Registered.

 

A description of the common stock, no par value per share (the “Common Stock”), of Akers Biosciences, Inc., a Nevada corporation (the “Registrant”) is set forth under the heading “Description of Securities” contained in the Registrant’s registration statement on Form S-1 (File No. 333-190456), as initially filed with the Securities and Exchange Commission (the “Commission”) on August 7, 2013, as amended (the “Registration Statement”), and in the prospectus included in the Registration Statement to be filed separately by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which prospectus shall be deemed to be incorporated by reference herein.

 

 

Item 2. Exhibits.

 

In accordance with the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed as part of this registration statement because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

      AKERS BIOSCIENCES, INC.
           
           
Date: January 17, 2014   By:  /s/ Thomas A. Nicolette  
        Name: Thomas A. Nicolette  
        Title: Chief Executive Officer